Third Party Infringement Claims. In the event that a Third Party shall make any claim, give notice, or bring any suit or other inter parties proceeding against ADCT or MedImmune, or any of their respective Affiliates or sublicensees or customers, for infringement or misappropriation of any intellectual property rights with respect to making, using, selling, offering for sale, or importing any Licensed Product (“Third Party Infringement Claim”), in each case, the Party receiving notice of a Third Party Infringement Claim shall promptly notify the other Party and provide all evidence in its possession pertaining to the claim or suit that it can disclose without breach of a pre-existing obligation to a Third Party or waiver of a privilege.
Appears in 4 contracts
Samples: License Agreement (ADC Therapeutics SA), License Agreement (ADC Therapeutics SA), License Agreement (ADC Therapeutics SA)
Third Party Infringement Claims. In the event that a Third Party shall make any claim, give notice, or bring any suit or other inter parties proceeding against ADCT Genmab or MedImmuneADCT, or any of their respective Affiliates or sublicensees licensees or customers, for infringement or misappropriation of any intellectual property rights with respect to the research, Development, making, using, selling, offering for sale, import or importing export of any Licensed Product ADC (“Third Third-Party Infringement Claim”), in each case, the Party receiving notice of a Third Third-Party Infringement Claim shall promptly notify the other Party and provide all evidence in its possession pertaining to the claim or suit that it can disclose without breach of a pre-existing obligation to a Third Party or waiver of a privilege.
Appears in 3 contracts
Samples: Collaboration and License Agreement (ADC Therapeutics SA), Collaboration and License Agreement (ADC Therapeutics SA), Collaboration and License Agreement (ADC Therapeutics SA)
Third Party Infringement Claims. In the event that a Third Party shall make any claim, give notice, or bring any suit or other inter parties proceeding against ADCT Genmab or MedImmuneADCT, or any of their respective Affiliates or sublicensees licensees or customers, for infringement or misappropriation of any intellectual property rights with respect to the research, Development, making, using, selling, offering for sale, import or importing export of any Licensed Product (“Third Third-Party Infringement Claim”), in each case, the Party receiving notice of a Third Third-Party Infringement Claim shall promptly notify the other Party and provide all evidence in its possession pertaining to the claim or suit that it can disclose without breach of a pre-existing obligation to a Third Party or waiver of a privilege.
Appears in 1 contract
Samples: Collaboration and License Agreement (ADC Therapeutics SA)